Incyte | INCY - Los Ingresos Por Intereses





Los Ingresos Por Intereses Cambio Fecha
Acadia Pharmaceuticals USD 8.33M 86K 2025-12
Agios Pharmaceuticals USD 12.41M 959K 2025-12
Alnylam Pharmaceuticals USD 26.63M 2.05M 2025-12
BioCryst Pharmaceuticals USD -0.13 3.59M 2024-12
Biogen USD 37.9M 700K 2026-03
BioMarin Pharmaceutical USD 22.56M 3.35M 2026-03
Eli Lilly USD 65M 25M 2025-09
Exelixis USD 16.13M 1.3M 2026-03
Gilead Sciences USD 95M 7M 2025-12
Incyte USD 33.69M 2.93M 2026-03
Ionis Pharmaceuticals USD -0.66 0.29 2024-12
MacroGenics USD 1.55M 26K 2026-03
Merck USD 69M 27M 2025-12
Moderna USD 70M 3M 2025-12
Nektar Therapeutics USD -0.18 0.07 2024-09
Pfizer USD 115M 51M 2026-03
Puma Biotechnology USD 0.41 0.5 2024-09
Regeneron Pharmaceuticals USD 193.3M 18.2M 2025-12
Sarepta Therapeutics USD 8.74M 359K 2025-12
Ultragenyx Pharmaceutical USD 6.51M 649K 2025-12
Vertex Pharmaceuticals USD 114.8M 7.1M 2026-03